Chemours Announces Board and Executive Changes
Ticker: CC · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, governance
Related Tickers: CC
TL;DR
Chemours shakes up its board and exec comp. Big changes coming?
AI Summary
On August 29, 2025, The Chemours Company filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. Specific details regarding the individuals involved and the exact nature of the compensatory changes are outlined within the report.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty and signal potential strategic shifts, which may carry inherent risks.
Key Players & Entities
- The Chemours Company (company) — Registrant
- August 29, 2025 (date) — Date of Report
- Delaware (location) — State of Incorporation
- 1007 Market Street Wilmington, Delaware 19801 (address) — Principal executive offices
FAQ
Who are the specific officers and directors departing from The Chemours Company?
The filing indicates the departure of certain officers and directors, but specific names are not provided in the summary information.
When were the new directors elected to The Chemours Company's board?
The filing reports on the election of new directors as of August 29, 2025.
What are the key changes in the compensatory arrangements for The Chemours Company's officers?
The filing notes updates to compensatory arrangements for certain officers, but the specific details of these changes are not elaborated in the provided summary.
What is the primary reason for the reported changes in directors and officers at Chemours?
The filing does not explicitly state the reason for the departures or appointments, only that these events occurred and are being reported.
Does this 8-K filing include information about The Chemours Company's financial performance?
This specific 8-K filing focuses on the departure of directors, election of directors, appointment of officers, and compensatory arrangements, not financial performance.
Filing Stats: 460 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2025-08-29 16:33:35
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- cc-20250829.htm (8-K) — 48KB
- img173611421_0.jpg (GRAPHIC) — 35KB
- 0001627223-25-000005.txt ( ) — 242KB
- cc-20250829.xsd (EX-101.SCH) — 29KB
- cc-20250829_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Shane Hostetter Shane Hostetter Senior Vice President, Chief Financial Officer Date: August 29, 2025